02196 FOSUN PHARMA
- 13.680
- -0.040-0.29%
FOSUN PHARMA News
FOSUN PHARMA: Overseas Regulatory Announcement - Announcement in Relation to the Acceptance ofa Subsidiary's Drug Registration Application
FOSUN PHARMA: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2024
FOSUN PHARMA: NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK
FOSUN PHARMA: NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK
FOSUN PHARMA: Overseas Regulatory Announcement - Progress Announcement on Providing Guarantees for Holding Subsidiaries.
FOSUN PHARMA: NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK
FOSUN PHARMA: Overseas Regulatory Announcement - Advisory announcement regarding the progress of absorption merger and privatization of the holding subsidiary HENLIUS Biotechnology Co., Ltd.
FOSUN PHARMA: Overseas Regulatory Announcement - Announcement regarding the pledge of part of the Shareholder's shares.
FOSUN PHARMA: Overseas Regulatory Announcement - Progress Announcement on Providing Guarantees for Holding Subsidiaries.
FOSUN PHARMA: ELECTION FORM FOR THE CASH ALTERNATIVE OR THE SHARE ALTERNATIVE
FOSUN PHARMA: (1) PROPOSED PRIVATISATION OF HENLIUS BY FOSUN NEW MEDICINE BY WAY OF MERGER BY ABSORPTION OF HENLIUS (2) PROPOSED WITHDRAWAL OF LISTING OF THE H SHARES OF HENLIUS (3) NOTICE OF THE EXTRAORDINARY GENERAL MEETING AND (4) NOTICE OF THE H SHAREHOLDERS' CLASS
FOSUN PHARMA: JOINT ANNOUNCEMENT - DESPATCH OF COMPOSITE DOCUMENT IN RELATION TO THE PROPOSED PRIVATISATION OF HENLIUS BY FOSUN NEW MEDICINE BY WAY OF MERGER BY ABSORPTION OF HENLIUS
FOSUN PHARMA: Overseas Regulatory Announcement - Progress Announcement on Providing Guarantees for Holding Subsidiaries.
FOSUN PHARMA: Overseas Regulatory Announcement - Announcement Regarding the Signing of a Licensing Agreement by a Wholly-Owned Subsidiary.
FOSUN PHARMA: CHANGE OF ADDRESS OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG
FOSUN PHARMA: Overseas regulatory announcement - Progress announcement on the absorption merger and privatization of the holding subsidiary henlius biotechnology co., ltd.
FOSUN PHARMA: JOINT ANNOUNCEMENT - FULFILMENT OF THE PRE-CONDITIONS OF THE PROPOSED PRE-CONDITIONAL PRIVATISATION OF HENLIUS BY FOSUN NEW MEDICINE BY WAY OF MERGER BY ABSORPTION OF HENLIUS
FOSUN PHARMA: NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK
FOSUN PHARMA: CONNECTED TRANSACTIONS IN RELATION TO ACQUISITION OF EQUITY INTERESTS IN THE TARGET FUNDS
FOSUN PHARMA: CONTINUING CONNECTED TRANSACTIONS (1) ENTERING INTO OF THE FRAMEWORK TENANCY AGREEMENTS AND (2) ENTERING INTO OF THE FOSUN INTERNATIONAL MUTUAL SUPPLY FRAMEWORK AGREEMENT
No Data
